03 July 2017 - Corporate News
FarmaMondo is delighted to announce further expansion of its Russian operations.
As of July 1st 2017 FarmaMondo Representative Office (Moscow, Russia) provides full service coverage to all Commonwealth Independent States (CIS) region.
The enlarged Representative Office is a part of FarmaMondo’s global strategy of putting in place localized solution through physical geographical expansion, all aimed to better support access to medicines where there is unmet medical needs.
Since 2013, FarmaMondo activities in Russia became one of FarmaMondo’s competitive advantages and present a remarkable opportunity to continue serving local patients through legal and compliant routes.
FarmaMondo SA is the perfect mechanism for those who need care, everywhere.
About FarmaMondo SA
FarmaMondo is a Swiss-based pharmaceutical company with a focus on providing patient access to their unmet medical need via Early-access, Named-patient and Compassionate-use mechanisms. Our global footprint includes commercial operations in more than 60 markets, headquartered from Switzerland with regional hubs in Europe, Asia and Latin America.
While pharmaceutical and biopharmaceutical innovators continuously develop and launch new medicines and therapies, in reality these are not equally available for all the world’s population for what can be substantial periods of time due to a mix of regulatory and commercial reasons.
FarmaMondo works with manufacturers by utilizing legal and regulatory compliant commercial routes to gain access to such therapies and deliver them in a timely and efficient manner to healthcare providers and practitioners wherever they are.
All FarmaMondo’s lines of business share the focus on providing patients and healthcare professionals, either Swiss or Global, the access to their unmet medical needs across the lifecycle of pharmaceutical products, prior and post regulatory approvals.